SRRM3 Activators are a diverse group of chemical compounds that indirectly enhance the functional activity of SRRM3 through a variety of signaling pathways. Forskolin, Isoproterenol, 8-Bromo-cyclic AMP, and Dibutyryl-cyclic AMP all function through the elevation of intracellular cAMP, which in turn activates protein kinase A (PKA). PKA is known to phosphorylate a variety of proteins, and such phosphorylation events can lead to the enhanced activity of SRRM3 by altering its conformation or interaction with other cellular components. Similarly, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), and through its phosphorylation targets, it may indirectly enhance the activity of SRRM3. Ionomycin and A23187 elevate intracellular calcium, which can activate calcium-dependent kinases that may also target and activate SRRM3. Retinoic acid engages in gene regulation that might upregulate proteins that positively regulate SRRM3, while Epigallocatechin gallate (EGCG) inhibits competing kinases, potentially skewing phosphorylation events in favor of SRRM3 activation.
Spermidine, through its involvement in various cellular processes, may influence signaling pathways leading to SRRM3 activation. LY294002, by inhibiting PI3K, could shift cellular signaling in a way that compensates by activating SRRM3 through alternative pathways. Lastly, PD98059 alters MAPK/ERK signaling, which might also initiate a cascade of compensatory cellular responses culminating in the activation of SRRM3. Each activator, despite its unique primary action, converges on a common theme: the enhancement of SRRM3 functional activity through the modulation of specific cellular signaling pathways. Collectively, these activators create an environment conducive to the promotion of SRRM3 activity without directly increasing its expression or requiring direct activation by upstream proteins.
Items 11 to 12 of 12 total
디스플레이 라벨:
| 제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002는 PI3K를 억제하는 약물로, AKT 신호 전달과 같은 하류 경로를 조절할 수 있습니다. 이러한 변조는 SRRM3의 기능적 활동을 강화하는 대체 경로의 보상적 활성화로 이어질 수 있습니다. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059는 MAPK/ERK 경로를 변경할 수 있는 MEK 억제제입니다. 이 경로를 억제하면 세포가 항상성을 유지하려고 할 때 SRRM3의 활성을 강화하는 보상 신호 메커니즘이 활성화될 수 있습니다. | ||||||